2023 press releases
- A neural organoid immune environment
Press release, 14 november 2023 - Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France
- Press release, 18 september 2023
- Gustave Roussy in the world's Top 5 cancer hospitals
Press release, 13 september 2023 - Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies
Press release, 7 september 2023 - ASCO 2023 : Urinary tract cancers - Evidence of superiority of targeted therapy over standard of care
Press release, 4 june 2023 - ASCO 2023 - BIOMEDE study systematizes molecular profiling to guide diagnosis and management in infiltrating brainstem glioma
Press release, 4 june 2023 - ASCO 2023 - Metastatic prostate cancer with DNA repair gene mutations: a highly promising combination of hormone therapy and PARP inhibitor
Press release, 4 june 2023 - ASCO 2023 - Benefits of radiotherapy combined with abiraterone and standard therapy in poorly metastatic prostate cancer
Press release, 4 june 2023 - ASCO 2023 - Predictive biomarkers of efficacy in targeted combination therapy for metastatic lung cancer with EGFR mutation
Press release, 2 june 2023 - Horizon Europe - the PREVALUNG EU program, which develops predictive biomarkers associated with lung cancer risk, receives 7 million euros from the European commission
Press release, 26th May 2023 - AACR congress : The origin and location of the macrophages in the tumors are decisive
Press release, 19th April 2023 - Dana-Farber and Gustave Roussy to hold Second Transatlantic Exchanges, a scientific Conference in Oncology
Press release, 30th march 2023 - An innovative technique to prevent and reduce some side effects of cancer treatment
Press release, 11th April 2023 - France is set to become a global leader in using AI to diagnose and treat diseases through €33 million Owkin-led AI project
Press release, 31st march 2023 - Gustave Roussy is launching Orakl, start-up aiming to improve and accelerate pharmaceutical research in oncology
Press release, 13th march 2023 - New England Journal of Medicine - Promising new inhibitor for prostate cancer with BRCA mutations
Press release, 17th february 2023 - Sanofi and Gustave Roussy are strengthening their strategic oncology research collaboration
Press release, 19th January 2023
Catégorie de la page:
